Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Conditioned Medium for Chronic Fatigue
jRCT1051240143Recruiting
- Sponsor
- Omotesando Wellness Clinic
- Start
- Oct 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in myalgic encephalomyelitis (ME), sponsored by Omotesando Wellness Clinic. Primary endpoints: Fatigue Visual Analogue Scale (VAS) and Chalder Fatigue Scale. Started Oct 2024; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on jRCT1051240143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051240143.